BACKGROUND: Ezetimibe is recommended by clinical practice guidelines as a second-line
therapy for lowering low-density lipoprotein cholesterol (LDL-C) levels, but little is known …

The ezetimibe/simvastatin [Vytorin] combination is superior to atorvastatin in reducing levels
of LDL-cholesterol, resulting in more patients achieving LDL-cholesterol goals, according to …

Background: Combining statins with ezetimibe synergistically enhances lipid lowering,
thereby reducing the need to prescribe maximal statin doses to achieve low-density …

Background: Efficacy and safety of ezetimibe (EZE) administered with atorvastatin (ATV) in
pts with primary hypercholesterolemia were assessed in a Phase III, multicenter …

BACKGROUND: Reducing low-density lipoprotein cholesterol (LDL-C) is the primary goal of
therapy in patients with hypercholesterolemia and coronary heart disease (CHD) …

Objective: To assess the efficacy, safety, and tolerability of a combination of 10 mg ezetimibe
and 20 mg simvastatin in Taiwanese patients with hypercholesterolemia. Research design …

Objectives: The purpose of this study was to assess the efficacy and safety of ezetimibe
administered with simvastatin in patients with primary hypercholesterolemia. Background …

Hypercholesterolemic patients (n= 1,547) at high atherosclerotic cardiovascular disease risk
with low-density lipoprotein cholesterol (LDL-C) levels≥ 100 and≤ 160 mg/dl while treated …

Conclusions: Response to initial statin dose predicts response to dose titration. Dose
titration of statins is therefore not an effective strategy to reach aggressive LDL goals in …

BACKGROUND:: Despite the need for effective and well-tolerated lipid-lowering therapies
for primary hypercholesterolemia in older patients, there is a relative paucity of published …